Beta-Defensin vs Vitamin D3 Injection
A side-by-side research comparison of Beta-Defensin and Vitamin D3 Injection across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Beta-Defensin | Vitamin D3 Injection |
|---|---|---|
| Full name | Human Beta-Defensin Peptides | Cholecalciferol (Vitamin D3) Injectable |
| Category | Immune Support | Immune Support |
| Status | Research compound | Compounded supplement |
| Mechanism | Form pores in microbial membranes causing lysis, recruit immune cells via CCR6 receptor chemotaxis, and bridge innate and adaptive immunity by activating dendritic cells. | Converts to 25-hydroxyvitamin D then to active 1,25-dihydroxyvitamin D. Modulates over 200 genes including those for immune function, calcium absorption, bone remodeling, and hormone production. |
| Molecular weight | 4000-5000 Da | 384.64 Da |
| Half-life | ~2-4 hours | ~15 days (storage form) |
| Bioavailability | Primarily local/mucosal activity | ~100% IM |
| Typical dose | 50-200 mcg | 50,000-100,000 IU |
| Frequency | Daily or as needed | Weekly to monthly |
| Route | Topical or subcutaneous | Intramuscular injection |
Beta-Defensin reported benefits
- Broad antimicrobial activity
- Immune cell recruitment
- Wound healing support
- Biofilm disruption
Vitamin D3 Injection reported benefits
- Rapid deficiency correction
- Immune system optimization
- Bone health
- Hormone support
- Mood improvement
- Reduced inflammation
Related comparisons
Research and educational reference only. Not medical advice.